Argus - Real-Time Stock Momentum Scanner

Medicus Pharma Ltd. (MDCX) announced a 50-to-1 share consolidation effective October 12; the company says voting power and share rights will remain unchanged.

A prospectus also identifies 3,245,595 common shares issuable upon warrant exercise.

argenx SE (ARGX) said an independent committee recommended stopping its Phase 3 UNITY study of efgartigimod in Sjögren’s disease for futility because it was unlikely to meet its primary endpoint. The company also reported that its Phase 2 FB102 study in celiac disease met its primary endpoint and plans to advance the program into Phase 3.

VCI Global (VCIG) announced the October 6 launch of its VGAIN Compute AI-token platform, describing a product expansion rather than a reported operational setback.

Pinnacle Food Group Ltd (PFAI) shareholders approved raising Class B shares’ voting power from five to twenty votes per share on October 6, subject to required Class B holder consents; the change concerns voting rights, not operating or financial results.

Stablecoin Development Corporation (SDEV) amended a resale registration covering up to 212,876,259 shares on October 6; those shares may be resold only after the registration becomes effective.

My Size, Inc. (MYSZ) registered up to 4,018,326 shares issuable upon warrant exercise for resale, a potential source of share supply; the filing does not say that holders sold shares. The registration statement became effective on October 8.

Toppoint Holdings Inc. (TOPP) said on October 7, at NYSE American’s request, that it was unaware of material undisclosed developments explaining unusual trading on October 6–7; the statement identifies no company-specific catalyst.

NFT Ltd. (NYSE American: MI)’s registered direct offering is a possible factor in today’s trading, but it was announced on October 6, before today’s session. The prospectus says shares underlying the common warrants equal approximately 235% of currently outstanding Class A shares.

MicroVision, Inc. (MVIS) reiterated its 2026 revenue outlook on October 7, leaving the forecast unchanged at $10 million to $15 million. The company also projected 2027 revenue to double, while its October 7 8-K described expected cost savings and lower cash burn in 2027.

Safe Harbor Financial Group (SHFS) reported preliminary third-quarter client deposits of approximately $119.3 million at September 30, up 9.6% sequentially; the company estimates this adds approximately $150,000 in annualized investment income.

Scienture Holdings, Inc. (SCNX) disclosed a 1-for-25 reverse stock split effective October 5; split-adjusted trading began that morning, before the 8-K became public on October 7. The company said the split was intended, among other things, to regain compliance with Nasdaq’s minimum bid-price requirement.

XChange TEC.INC (XHG) outlined a proposed U.S. AI expansion and planned reduction of mainland China operations on October 6, but its $5 million to $10 million investment depends on financing, market conditions and suitable opportunities.

Lipocine Inc.'s Health Canada approval of TLANDO may be relevant today, but the announcement describes a positive regulatory development, not a negative business event. An October 7 Form 8-K says Verity Pharmaceuticals plans to launch TLANDO in Canada by the end of 2026.

Safe Pro Group Inc. (SPAI) reported preliminary third-quarter revenue above $2.5 million, up over 2,300% year over year; the unaudited estimates describe strong growth, not a negative business development.